C
Cadrenal Therapeutics Inc
NASDAQ:CVKD
Cadrenal Therapeutics Inc
NASDAQ:CVKD
Price:
6.21
USD
12.5%
Market Closed
Market Cap:
$14.5m
Income Statement
Earnings Waterfall
Cadrenal Therapeutics Inc
Cadrenal Therapeutics Inc
Income Statement
Cadrenal Therapeutics Inc
Cadrenal Therapeutics Inc
Currency: USD
| Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||
| Operating Expenses |
(3)
|
(5)
|
(8)
|
(11)
|
(13)
|
(14)
|
(15)
|
|
| Selling, General & Administrative |
(2)
|
(3)
|
(5)
|
(7)
|
(8)
|
(9)
|
(10)
|
|
| Research & Development |
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
(3)
N/A
|
(5)
-82%
|
(8)
-45%
|
(11)
-38%
|
(13)
-20%
|
(14)
-10%
|
(15)
-2%
|
|
| Pre-Tax Income | ||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(3)
N/A
|
(5)
-85%
|
(8)
-46%
|
(11)
-40%
|
(13)
-20%
|
(14)
-10%
|
(14)
-2%
|
|
| Net Income | ||||||||
| Income from Continuing Operations |
(3)
|
(5)
|
(8)
|
(11)
|
(13)
|
(14)
|
(14)
|
|
| Net Income (Common) |
(3)
N/A
|
(5)
-85%
|
(8)
-46%
|
(11)
-40%
|
(13)
-20%
|
(14)
-10%
|
(14)
-2%
|
|
| EPS (Diluted) |
-2.63
N/A
|
-4.87
-85%
|
-6.89
-41%
|
-8.73
-27%
|
-6.95
+20%
|
-7.19
-3%
|
-7.03
+2%
|
|
Switch to:
Switch to:
See Also
Discover More
